Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: a systematic analysis of the literature and meta-analysis

Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: a systematic analysis of the literature and meta-analysis

Abstract Objectives To systematically review the impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and severe adverse events (SAEs) in patients with rheumatoid arthritis (RA) or axial spondyloarthritis (axSpA) in remission or low disease activity (LDA) state....

Full description

Bibliographic Details
Main Authors: D. Vinson, L. Molet-Benhamou, Y. Degboé, A. den Broeder, F. Ibrahim, C. Pontes, R. Westhovens, J. Závada, T. Pham, T. Barnetche, A. Constantin, A. Ruyssen-Witrand
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Arthritis Research & Therapy
Subjects:
Rheumatoid arthritis
Spondyloarthritis
Biological therapies
DMARDs
Infection bacteria
Viruses infection
Online Access:http://link.springer.com/article/10.1186/s13075-020-02188-x

Internet

http://link.springer.com/article/10.1186/s13075-020-02188-x

Similar Items